Contact
Spanish

Midatech is a nanomedicine company focused on the development and commercialisation of multiple, high-value, targeted therapies for major diseases with unmet medical need.

Midatech is advancing a pipeline of novel clinical and pre-clinical product candidates based on its proprietary drug conjugate and sustained release delivery platforms with a clear focus on the key therapeutic areas of diabetes, cancer and neuroscience/ophthalmology. Midatech’s strategy is to develop its products in-house in rare cancers and with partners in other indications, and to accelerate growth of its business through strategic acquisition of complementary products and technologies.

Latest News...
Dec 17, 2014
Midatech Pharma (AIM: MTPH), a nanomedicine company developing and commercialising multiple therapeutic... Read More
Dec 8, 2014
Oxford, UK - Midatech Pharma PLC (AIM: MTPH, “Midatech” or the “Company”) is pleased to announce the... Read More
Dec 8, 2014
Oxford, UK – Midatech, a nanomedicine company developing and commercialising multiple therapeutic... Read More
Home

Careers

T&Cs

Privacy and cookie policy

Sitemap

  © Copyright 2014 Midatech